. Lessons Learned from Approval of Aducanumab for Alzheimer's Disease. Annu Rev Med. 2024 Jan 29;75:99-111. PubMed.

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.